Naphthyridinone derivatives
    1.
    发明授权
    Naphthyridinone derivatives 失效
    萘啶衍生物

    公开(公告)号:US5854257A

    公开(公告)日:1998-12-29

    申请号:US809580

    申请日:1997-04-24

    CPC分类号: C07D471/04

    摘要: Compounds of formula I ##STR1## including pharmaceutically acceptable salts thereof in which R.sub.1 represents a phenyl C.sub.1-6 alkyl group (in which the phenyl ring is optionally substituted by one or more of the following: halo, a C.sub.1-4 alkyl group, a C.sub.1-4 alkoxy group, hydroxy or trifluoromethyl) and the alkyl chain is optionally substituted by one or more C.sub.1-2 alkyl groups; R.sub.2 represents a C.sub.2-6 alkoxycarbonyl group; and R.sub.3 represents hydrogen or halo are disclosed, which are antirheumatic agents and are useful as modulators of cytokine synthesis, immunomodulatory agents, antiinflammatory agents and anti-allergic agents. Compositions containing these compounds and processes to make these compounds are also disclosed.

    摘要翻译: PCT No.PCT / EP95 / 03808 Sec。 371日期1997年3月24日 102(e)1997年3月24日PCT PCT 1995年9月26日PCT公布。 第WO96 / 11199号公报 日期:1996年4月18日I式I化合物包括其药学上可接受的盐,其中R 1表示苯基C 1-6烷基(其中苯环任选被以下一个或多个取代:卤素,C1 -4-烷基,C 1-4烷氧基,羟基或三氟甲基),烷基链任选被一个或多个C 1-2烷基取代; R2表示C2-6烷氧基羰基; 和R 3表示氢或卤素,其是抗风湿剂,并且可用作细胞因子合成的调节剂,免疫调节剂,抗炎剂和抗过敏剂。 还公开了含有这些化合物的组合物和制备这些化合物的方法。

    Condensed 4-aminopyridines with antirheumatic activity
    2.
    发明授权
    Condensed 4-aminopyridines with antirheumatic activity 失效
    具有抗风湿活性的冷凝的4-氨基吡啶

    公开(公告)号:US5780482A

    公开(公告)日:1998-07-14

    申请号:US564154

    申请日:1995-12-21

    CPC分类号: C07D471/04 C07H15/26

    摘要: Compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof in which one of A or B represents N and the other represents N or C--R.sub.3 ; R.sub.1 represents hydrogen, halo, alkyl, hydroxy, carboxyalkenyl, alkoxycarbonylalkenyl, hydroxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, alkoxy, halogenated alkyl, carboxy, alkoxycarbonyl, alkanoylamino or carbamoylalkenyl; R.sub.2 represents hydrogen, alkyl, halo, alkoxy, hydroxy, alkanoyloxy, or phenoxy; R.sub.3 represents hydrogen or alkyl; R.sub.4 represents hydrogen, halo, alkoxycarbonyl, cyano, benzyloxycarbonyl, alkanoyl, benzoyl, alkyl, carboxy, alkylthio or carbamoyl; R.sub.5 represents hydrogen or alkyl; R.sub.9 represents hydrogen or alkyl; R.sub.10 represents phenyl, pyridyl or pyrimidinyl substituted by OR.sub.6 and optionally further substituted wherein R.sub.6 represents hydrogen, alkyl, alkoxycarbonyl or carbamoyl, alicyclic hydrocarbon, phenyl, cycloalkylalkyl, arylalkyl or pyridyl; or when R.sub.10 represents phenyl, OR.sub.6 represents a monosaccharide group or a disaccharide group; which are antirheumatic agents. Compositions containing these compounds and processes to prepare them are also disclosed.

    摘要翻译: PCT No.PCT / EP94 / 01923 Sec。 371 1995年12月21日第 102(e)日期1995年12月21日PCT提交1994年6月10日PCT公布。 第WO95 / 00511号公报 日期:1月5日,I式I化合物及其药学上可接受的盐,其中A或B中的一个为N,另一个为N或C-R 3; 羧基,烷氧基羰基烷基,烷氧基,卤代烷基,羧基,烷氧基羰基,烷酰基氨基或氨基甲酰基烯基; R 1表示氢,卤素,烷基,羟基,羧基烯基,烷氧基羰基, R2代表氢,烷基,卤素,烷氧基,羟基,烷酰氧基或苯氧基; R3表示氢或烷基; R4代表氢,卤素,烷氧基羰基,氰基,苄氧基羰基,烷酰基,苯甲酰基,烷基,羧基,烷硫基或氨基甲酰基; R5代表氢或烷基; R9代表氢或烷基; R 10表示被OR 6取代的苯基,吡啶基或嘧啶基,任选进一步取代,其中R 6表示氢,烷基,烷氧基羰基或氨基甲酰基,脂环族烃,苯基,环烷基烷基,芳基烷基或吡啶基。 或当R 10表示苯基时,OR 6表示单糖基或二糖基; 它们是抗风湿剂。 还公开了含有这些化合物的组合物和其制备方法。

    Naphthyridine derivatives
    3.
    发明授权
    Naphthyridine derivatives 失效
    萘啶衍生物

    公开(公告)号:US5712286A

    公开(公告)日:1998-01-27

    申请号:US809581

    申请日:1997-03-24

    CPC分类号: C07D471/04

    摘要: Compounds of formula (I) including pharmaceutically acceptable salts thereof in which R.sub.1 represents a C.sub.1-6 alkyl group; R.sub.2 represents a group of the formula COOR.sub.4 in which R.sub.4 represents a C.sub.1-5 alkyl group; and R.sub.3 represents a group of formula COOR.sub.5 in which R.sub.5 represents a C.sub.1-5 alkyl group are disclosed, which are anti-rheumatic agents and are useful as modulators of cytokine synthesis, immunomodulatory agents, anti-inflammatory agents and anti-allergic agents. Compositions containing these compounds and processes to make these compounds are also disclosed.

    摘要翻译: PCT No.PCT / EP95 / 03769 Sec。 371日期1997年3月24日 102(e)1997年3月24日PCT PCT 1995年9月23日PCT公布。 公开号WO96 / 11198 日期:1996年4月18日,式(I)化合物,其包括其药学上可接受的盐,其中R 1表示C 1-6烷基; R2代表式为COOR4的基团,其中R4代表C1-5烷基; R3代表其中R5代表C1-5烷基的式COOR5基团,其为抗风湿剂,可用作细胞因子合成的调节剂,免疫调节剂,抗炎剂和抗过敏剂。 还公开了含有这些化合物的组合物和制备这些化合物的方法。